Table - PMC 13/03/24 16.

05

Table 3
Vaccines recommendations in chronic kidney disease (CKD) patients and kidney transplant (KT)
recipients.

Pre-Transplant Post-Transplant
Timing Schedule Timing Schedule
Each winter,
3–6 months after KT (as early as 1
at least 2
Influenza Single dose month after KT in case of outbreak Single dose
weeks prior
but avoiding LAV)
KT
At least 2 PCV13 followed by PCV13 followed
Streptococcus
weeks prior PPSV23 8 weeks 3–6 months after KT by PPSV23 8
pneumoniae
KT later weeks later
At least 2 0, 1 and 2 and/or 6
HBV weeks prior months depending on 3–6 months after KT 0, 1 and 6 months
KT type of vaccine
At least 2
As general
HAV weeks prior As general population 3–6 months after KT
population
KT
At least 2
As general
SARS-CoV-2 weeks prior As general population 3–6 months after KT
population
KT
2 weeks for HZV not recommended, RZV, 3–6 2 doses at least 8
HZV As general population
RZV months after KT weeks apart
At least 2
As general
Meningococcal weeks prior As general population 3–6 months after KT
population
KT
0, 2, 6 months,
At least 2
monovalent
HPV weeks prior As general population 3–6 months after KT
vaccine up to 45
KT
years

KT, kidney transplant; CKD, chronic kidney disease; LAVs, live attenuated vaccines; LZV, live attenuated zoster vaccine;
PCV13, 13-valent pneumococcal conjugate vaccine; PPSV23, 23-valent pneumococcal polysaccharide vaccine; RZV,
recombinant zoster vaccine; HAV, hepatitis A virus; HBV, hepatitis B; HPV, human papilloma virus; HZV, herpes zoster virus;
MMR, measles, mumps and rubella; Tdap, tetanus toxoid, reduced diphtheria toxoid, acellular pertussis; Td, tetanus diphtheria;
BCG, bacille Calmette–Guerin.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611006/table/vaccines-11-01611-t003/?report=objectonly Page 1 of 1